Related Experiment Videos
Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction
1Russell H. Morgan Department of Radiology, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Summary
Vascular autoregulation disorders can cause reversible brain abnormalities visible on CT and MRI scans. Early recognition of hypertensive and uremic encephalopathies aids timely treatment.
Area of Science:
- Neurology
- Radiology
- Vascular Biology
Background:
- Cerebral pathologic processes often stem from impaired vascular autoregulation.
- Hypertensive and uremic encephalopathies are key examples of such conditions.
- Imaging plays a crucial role in diagnosing these reversible neurological disorders.
Purpose of the Study:
- To describe the characteristic neuroimaging findings in hypertensive and uremic encephalopathies.
- To highlight the reversibility of these abnormalities on CT and MRI.
- To emphasize the importance of early radiologic recognition for prompt therapeutic intervention.
Main Methods:
- Review of computed tomographic (CT) and magnetic resonance (MR) imaging findings.
- Correlation of imaging abnormalities with clinical conditions of hypertensive and uremic encephalopathies.
- Analysis of lesion characteristics, including location, symmetry, mass effect, and enhancement patterns.
Main Results:
- Hypertensive encephalopathies (e.g., preeclampsia, cyclosporine toxicity) show symmetric, confluent subcortical white matter lesions in occipital lobes with patchy enhancement.
- Uremic encephalopathies (e.g., uremia, hemolytic-uremic syndrome) present with symmetric basal ganglia edema, potentially progressing to infarcts or hemorrhage.
- These imaging abnormalities are often reversible with appropriate management.
Conclusions:
- Neuroimaging is vital for identifying reversible cerebral abnormalities in vascular autoregulation disorders.
- Distinct imaging patterns differentiate hypertensive from uremic encephalopathies.
- Earlier radiologic diagnosis facilitates timely initiation of effective therapies, improving patient outcomes.